Dr. Nacev is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 East 66th Street
New York, NY 10065Phone+1 646-888-6853
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Johns Hopkins UniversityResidency, Internal Medicine, 2013 - 2016- Johns Hopkins University School of MedicineClass of 2013, MD, PhD
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2018 - 2024
PA State Medical License 2022 - 2024
NJ State Medical License 2021 - 2023
NC State Medical License 2020 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 7 citationsA High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma.Christina V. Angeles, Ana Velez, Jordan Rios, Bernadette Laxa, David Shum
Clinical Cancer Research. 2021-10-19 - 120 citationsThe epigenomics of sarcoma.Benjamin A. Nacev, Kevin B. Jones, Andrew M. Intlekofer, Jamie S.E. Yu, C. David Allis
Nature Reviews. Cancer. 2020-08-11 - 235 citationsThe expanding landscape of ‘oncohistone’ mutations in human cancersBenjamin A. Nacev, Lijuan Feng, John D. Bagert, Agata E. Lemiesz, Jianjiong Gao
Nature. 2019-03-01
Press Mentions
Damon Runyon Cancer Research Foundation Awards $3.6 Million to Top Clinical InvestigatorsJuly 21st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
